Xin Yao

2.4k total citations · 1 hit paper
40 papers, 1.8k citations indexed

About

Xin Yao is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Xin Yao has authored 40 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 14 papers in Immunology and 8 papers in Molecular Biology. Recurrent topics in Xin Yao's work include Immunotherapy and Immune Responses (11 papers), CAR-T cell therapy research (9 papers) and Immune Cell Function and Interaction (7 papers). Xin Yao is often cited by papers focused on Immunotherapy and Immune Responses (11 papers), CAR-T cell therapy research (9 papers) and Immune Cell Function and Interaction (7 papers). Xin Yao collaborates with scholars based in China, United States and Israel. Xin Yao's co-authors include Steven A. Rosenberg, Paul F. Robbins, Yong F. Li, Mark E. Dudley, Daniel C. Douek, Jorge R. Almeida, Alena Gros, James Chih‐Hsin Yang, John R. Wunderlich and Ken‐ichi Hanada and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and Blood.

In The Last Decade

Xin Yao

36 papers receiving 1.7k citations

Hit Papers

PD-1 identifies the patient-specific CD8+ tumor-reactive ... 2014 2026 2018 2022 2014 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. PD-1 identifies the patient-specific CD8+ tumor-reactive repertoire infiltrating human tumors
    2014 772 citations Alena Gros, Paul F. Robbins et al. profile →

Peers

Xin Yao
Jiacheng Bi China
Nikolaos Svoronos United States
Derese Getnet United States
Sandra Tuyaerts Belgium
Frédéric Coutant France
Dass S. Vinay United States
Ravikumar Muthuswamy United States
Thomas Calzascia Switzerland
Andrea Kruse Germany
Jiacheng Bi China
Xin Yao
Citations per year, relative to Xin Yao Xin Yao (= 1×) peers Jiacheng Bi

Countries citing papers authored by Xin Yao

Since Specialization
Citations

This map shows the geographic impact of Xin Yao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xin Yao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xin Yao more than expected).

Fields of papers citing papers by Xin Yao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xin Yao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xin Yao. The network helps show where Xin Yao may publish in the future.

Co-authorship network of co-authors of Xin Yao

This figure shows the co-authorship network connecting the top 25 collaborators of Xin Yao. A scholar is included among the top collaborators of Xin Yao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xin Yao. Xin Yao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Qiu, Xiangyu, Zhiliang Zhang, Xin Yao, et al.. (2025). Naringenin: A potential therapeutic agent for modulating angiogenesis and immune response in hepatocellular carcinoma. Journal of Pharmaceutical Analysis. 15(9). 101254–101254. 1 indexed citations
2.
Wu, Qi, et al.. (2025). Sedative-hypnotic effects of Yiyin Anshen Granule on mice models of insomnia by regulating neurotransmitters, cytokines, and gut microbiota. Journal of Pharmaceutical and Biomedical Analysis. 263. 116949–116949.
3.
Yao, Xin, et al.. (2025). Cuproptosis in atrazine-induced hepatotoxicity: ATOX1 as a therapeutic target for lycopene-mediated protection. Journal of Advanced Research. 2 indexed citations
4.
Yang, Chuan, Tianfeng Chai, Xin Yao, et al.. (2025). Impact of fospropofol disodium on lipid metabolism and inflammatory response in patients with hyperlipidemia: a randomized trial. BMC Anesthesiology. 25(1). 99–99.
5.
Duan, Hongtao, Changjian Shao, Tianhu Wang, et al.. (2024). Perioperative sintilimab and neoadjuvant anlotinib plus chemotherapy for resectable non-small-cell lung cancer: a multicentre, open-label, single-arm, phase 2 trial (TD-NeoFOUR trial). Signal Transduction and Targeted Therapy. 9(1). 296–296. 5 indexed citations
6.
7.
Zhang, Xiaojing, Wenke Zhang, Yuanyuan Dou, et al.. (2022). Cinobufotalin inhibits the epithelial-mesenchymal transition of hepatocellular carcinoma cells through down-regulate β-catenin in vitro and in vivo. European Journal of Pharmacology. 922. 174886–174886. 16 indexed citations
8.
Yang, Jun Young, et al.. (2021). Gravity determines the direction of nerve roots sedimentation in the lumbar spinal canal. BMC Musculoskeletal Disorders. 22(1). 154–154. 2 indexed citations
9.
Ding, Zhenjiang, Chao Liang, Xiao Wang, et al.. (2020). Antihypertensive Activity of Eucommia Ulmoides Oliv: Male Flower Extract in Spontaneously Hypertensive Rats. Evidence-based Complementary and Alternative Medicine. 2020(1). 6432173–6432173. 21 indexed citations
10.
Luo, Xiaobing, Huijuan Cui, Lun Cai, et al.. (2020). Selection of a Clinical Lead TCR Targeting Alpha-Fetoprotein-Positive Liver Cancer Based on a Balance of Risk and Benefit. Frontiers in Immunology. 11. 623–623. 27 indexed citations
11.
12.
Prickett, Todd D., Jessica S. Crystal, Cyrille J. Cohen, et al.. (2016). Durable Complete Response from Metastatic Melanoma after Transfer of Autologous T Cells Recognizing 10 Mutated Tumor Antigens. Cancer Immunology Research. 4(8). 669–678. 88 indexed citations
13.
Xue, Feng, Brandon W. Higgs, Jiaqi Huang, et al.. (2015). HERC5 is a prognostic biomarker for post-liver transplant recurrent human hepatocellular carcinoma. Journal of Translational Medicine. 13(1). 379–379. 27 indexed citations
14.
Zou, Qiang, Xin Yao, Zhinan Yin, et al.. (2011). Praziquantel Facilitates IFN-γ-Producing CD8+ T Cells (Tc1) and IL-17-Producing CD8+ T Cells (Tc17) Responses to DNA Vaccination in Mice. PLoS ONE. 6(10). e25525–e25525. 13 indexed citations
15.
Yao, Xin, Mojgan Ahmadzadeh, Steven A. Rosenberg, & Paul D. Robbins. (2010). Reconstitution of peripheral CD4+FOXP3+ regulatory T cells in cancer patients receiving adoptive immunotherapy is related to the clinical response to therapy. (131.18). The Journal of Immunology. 184(Supplement_1). 131.18–131.18. 2 indexed citations
16.
Yang, Bing, et al.. (2010). Establishment of an aging model of Sca-1+ hematopoietic stem cell and studies on its relative biological mechanisms. In Vitro Cellular & Developmental Biology - Animal. 47(2). 149–156. 8 indexed citations
17.
Xing, Dajun, William K. Decker, Simon N. Robinson, et al.. (2006). AML-loaded DC generate Th1-type cellular immune responses in vitro. Cytotherapy. 8(2). 95–104. 7 indexed citations
18.
Yang, Hong, Connie J. Eaves, M. Lima, et al.. (2006). A novel triple purge strategy for eliminating chronic myelogenous leukemia (CML) cells from autografts. Bone Marrow Transplantation. 37(6). 575–582. 6 indexed citations
19.
20.
Gan, Judith, et al.. (1999). DONOR-TYPE CHIMERISM DETERMINATION BY COMPETITIVE POLYMERASE CHAIN REACTION (PCR) IN A PRIMATE MODEL FOR BONE MARROW TRANSPLANTATION1. Transplantation. 68(10). 1573–1577. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jiacheng Bi Breakdown of academic impact, for papers by Nikolaos Svoronos Breakdown of academic impact, for papers by Derese Getnet Breakdown of academic impact, for papers by Sandra Tuyaerts Breakdown of academic impact, for papers by Frédéric Coutant Breakdown of academic impact, for papers by Dass S. Vinay Breakdown of academic impact, for papers by Ravikumar Muthuswamy Breakdown of academic impact, for papers by Thomas Calzascia Breakdown of academic impact, for papers by Andrea Kruse
Rankless by CCL
2026